Yi Larson - 14 Sep 2023 Form 3 Insider Report for RayzeBio, Inc.

Role
Director
Signature
/s/ Jeff Woodley, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
14 Sep 2023
Net transactions value
$0
Form type
3
Filing time
14 Sep 2023, 19:27:58 UTC
Previous filing
21 Jun 2023
Next filing
27 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding RYZB Employee Stock Option (Right to Buy) 14 Sep 2023 Common Stock 59,399 $1.86 Direct F1
holding RYZB Employee Stock Option (Right to Buy) 14 Sep 2023 Common Stock 14,332 $3.24 Direct F2
holding RYZB Employee Stock Option (Right to Buy) 14 Sep 2023 Common Stock 40,848 $3.24 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is subject to an early exercise provision and is immediately exercisable. Vesting is monthly over a 36-month period starting May 1, 2021 in equal monthly amounts.
F2 The option is subject to an early exercise provision and is immediately exercisable. Vesting is monthly over a 36-month period starting October 29, 2021 in equal monthly amounts.
F3 The option is subject to an early exercise provision and is immediately exercisable. Vesting is monthly over a 36-month period starting January 1, 2023 in equal monthly amounts.

Remarks:

Exhibit 24 - Power of Attorney